Skin hyperreactivity of Behcet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders

Myeloid Leukaemia ◽

Interferon Alpha ◽

Pathergy Reaction

Monitoring of remission status by fluorescence in situ hybridisation in chronic myeloid leukaemia patients treated with interferon-alpha.

International Journal of Oncology ◽

10.3892/ijo.14.1.145 ◽

1999 ◽

Author(s):

H C Duba ◽

S Peter ◽

W Hilbe ◽

T Fluckinger ◽

M Fridrik ◽

...

Keyword(s):

Myeloid Leukaemia ◽

Interferon Alpha ◽

In Situ Hybridisation ◽

Fluorescence In Situ Hybridisation ◽

Remission Status

Granulomatous bone marrow inflammation during treatment of chronic myeloid leukaemia with interferon alpha-2b.

Journal of Clinical Pathology ◽

10.1136/jcp.48.9.878 ◽

1995 ◽

Vol 48 (9) ◽

pp. 878-880 ◽

Cited By ~ 5

Author(s):

A Siboni ◽

T Mourits-Andersen ◽

J Moesner

Keyword(s):

Bone Marrow ◽

Myeloid Leukaemia ◽

Interferon Alpha ◽

Interferon Alpha 2B

THERAPY WITH RECOMBINANT INTERFERON ALPHA-2c DURING UNEXPECTED PREGNANCY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA

10.1111/j.1365-2141.1992.tb06447.x ◽

1992 ◽

Vol 82 (2) ◽

pp. 472-473 ◽

Cited By ~ 21

Author(s):

Romeo P. Reichel ◽

Werner Linkesch ◽

Doris Schetitska

Keyword(s):

Myeloid Leukaemia ◽

Interferon Alpha ◽

Recombinant Interferon ◽

Recombinant Interferon Alpha

ELIMINATION BY INTERFERON-ALPHA OF MALIGNANT CLONE IN CHRONIC MYELOID LEUKAEMIA

The Lancet ◽

10.1016/s0140-6736(89)92733-5 ◽

1989 ◽

Vol 333 (8650) ◽

pp. 1334 ◽

Cited By ~ 17

Author(s):

B. Opalka ◽

O. Kloke ◽

C.R. Bartram ◽

U. Beer ◽

J.W.G. Janssen ◽

...

Keyword(s):

Myeloid Leukaemia ◽

Interferon Alpha

Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia

10.1111/j.1365-2141.2000.02361.x ◽

2000 ◽

Vol 111 (2) ◽

pp. 596-607 ◽

Cited By ~ 1

Author(s):

Xiao Chen ◽

Sybille Regn ◽

Silke Raffegerst ◽

Hans-Jochem Kolb ◽

Marie Roskrow

Keyword(s):

T Cell ◽

Myeloid Leukaemia ◽

Interferon Alpha ◽

Cell Response ◽

Antigen Presenting Cells ◽

T Cell Response ◽

Cytotoxic T Cell ◽

Gm Csf ◽

Antigen Presenting

MANAGEMENT OF RESISTANCE TO LYMPHOBLASTOID INTERFERON ALPHA IN CHRONIC MYELOID LEUKAEMIA

10.1046/j.1365-2141.1998.1161c.x ◽

1998 ◽

Vol 103 (4) ◽

pp. 1208-1209

Author(s):

Barton ◽

Green

Keyword(s):

Myeloid Leukaemia ◽

Interferon Alpha ◽

Lymphoblastoid Interferon

Evaluation of cytogenetic conversion to Ph − haemopoiesis in long‐term bone marrow culture for patients with chronic myeloid leukaemia on conventional hydroxyurea therapy, on pulse high‐dose hydroxyurea and on interferon‐alpha

10.1046/j.1365-2141.1996.d01-1733.x ◽

1996 ◽

Vol 93 (4) ◽

pp. 869-877 ◽

Cited By ~ 4

Author(s):

L. H. Coutinho ◽

M. L. Brereton ◽

A. M. W. Santos ◽

W. D. J. Ryder ◽

J. Chang ◽

...

Keyword(s):

Bone Marrow ◽

Myeloid Leukaemia ◽

Interferon Alpha ◽

Bone Marrow Culture ◽

High Dose ◽

Hydroxyurea Therapy

Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia

10.1046/j.1365-2141.2000.02361.x ◽

2000 ◽

Vol 111 (2) ◽

pp. 596-607 ◽

Cited By ~ 42

Author(s):

Xiao Chen ◽

Sybille Regn ◽

Silke Raffegerst ◽

Hans-Jochem Kolb ◽

Marie Roskrow

Keyword(s):

T Cell ◽

Myeloid Leukaemia ◽

Interferon Alpha ◽

Cell Response ◽

Antigen Presenting Cells ◽

T Cell Response ◽

Cytotoxic T Cell ◽

Gm Csf ◽

Antigen Presenting

Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia

10.1111/j.1365-2141.1994.tb03257.x ◽

1994 ◽

Vol 86 (1) ◽

pp. 92-96 ◽

Cited By ~ 15

Author(s):

Patricia C. A. Shepherd ◽

Susan Richards ◽

N. C. Allan

Keyword(s):

Myeloid Leukaemia ◽

Interferon Alpha

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial

Leukemia ◽

10.1038/s41375-020-01117-w ◽

2021 ◽

Author(s):

Francois Guilhot ◽

◽

Françoise Rigal-Huguet ◽

Joëlle Guilhot ◽

Agnès-Paule Guerci-Bresler ◽

...

Keyword(s):

Myeloid Leukaemia ◽

Interferon Alpha ◽

Randomised Trial ◽

Pegylated Interferon ◽

Phase Iii ◽

Term Outcome ◽

Long Term Outcome ◽

Pegylated Interferon Alpha